Current challenges for using the Kansas City Cardiomyopathy Questionnaire to obtain a standardized patient‐reported health status outcome
Open Access
- 23 February 2021
- journal article
- editorial
- Published by Wiley in European Journal of Heart Failure
- Vol. 23 (2), 205-207
- https://doi.org/10.1002/ejhf.2139
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureThe New England Journal of Medicine, 2021
- Minimal clinically important difference in quality of life scores for patients with heart failure and reduced ejection fractionEuropean Journal of Heart Failure, 2020
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection FractionCirculation, 2020
- Health-Related Quality of Life in Heart Failure With Preserved Ejection FractionJACC: Heart Failure, 2019
- Does heart failure-specific health status identify patients with bothersome symptoms, depression, anxiety, and/or poorer spiritual well-being?European Heart Journal - Quality of Care & Clinical Outcomes, 2019
- Relationship between changing patient‐reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF‐ACTIONEuropean Journal of Heart Failure, 2018
- Health-Related Quality of Life Outcomes in PARADIGM-HFCirculation: Heart Failure, 2017
- Development and Validation of a Short Version of the Kansas City Cardiomyopathy QuestionnaireCirculation: Cardiovascular Quality and Outcomes, 2015
- Identifying Heart Failure Patients at High Risk for Near-Term Cardiovascular Events With Serial Health Status AssessmentsCirculation, 2007
- Monitoring clinical changes in patients with heart failure: A comparison of methodsAmerican Heart Journal, 2005